Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo Joins J&J in $200 Million Fund With Index Ventures
Bloomberg
Wednesday, March 21, 2012 - 10:06am
tags:
GSK, JNJ, venture capital
Why Pfizer, Bristol And Mylan Will Skyrocket
Seeking Alpha
Wednesday, March 21, 2012 - 10:05am
tags:
Pfizer, Mylan, Bristol-Myers Squibb
The Best High Dividend Pharma Stocks
Motley Fool
Wednesday, March 21, 2012 - 10:05am
tags:
dividends, AstraZeneca, Pfizer, Sanofi, Merck, Eli Lilly, GSK
FDA panel does not recommend Taltorvic
Reuters
Wednesday, March 21, 2012 - 10:03am
tags:
soft tissue sarcomas, FDA, advisory panels, Taltorvic, Merck, Ariad Pharmaceuticals
FDA panel recommends Glaxo's Votrient for sarcoma
Yahoo/Reuters
Wednesday, March 21, 2012 - 10:02am
tags:
FDA, advisory panel, Votrient, sarcoma, GSK
Protalix: What You Need To Know Ahead Of The May 1 PDUFA Date
Seeking Alpha
Wednesday, March 21, 2012 - 10:01am
tags:
FDA, Pfizer, Sanofi, Shire, taliglucerase alfa, Gaucher disease, Protalix BioTherapeutics
EASL Gives Wall Street's Privileged Investors Sneaky Preview to Key Hep C Data
TheStreet.com
Tuesday, March 20, 2012 - 11:47am
tags:
hepatitis C, EASL, Gilead, Bristol-Myers Squibb, Abbott Laboratories, Vertex, Merck
3 Hot Pharmas With Skin In The Game
Seeking Alpha
Tuesday, March 20, 2012 - 10:40am
tags:
DUSA pharmaceuticals, Anika, Obagi Medical Products, anti-aging
Roche takes its case to Illumina shareholders
Reuters
Tuesday, March 20, 2012 - 10:37am
tags:
Roche, Illumina, M&A
Loss at XOMA Wider Than Expected
Yahoo/Zacks
Tuesday, March 20, 2012 - 10:36am
tags:
earnings, Xoma
Cyclacel: An Intriguing Long Shot
Seeking Alpha
Tuesday, March 20, 2012 - 10:35am
tags:
Cyclacel, Sapacitabine, cancer, Daiichi Sankyo
Why Bristol-Myers Squibb's Earnings Are Outstanding
Motley Fool
Tuesday, March 20, 2012 - 10:34am
tags:
earning, Bristol-Myers Squibb
Eli Lilly to Focus on Cancer, Diabetes in China, CEO Says
Bloomberg
Tuesday, March 20, 2012 - 10:31am
tags:
Eli Lilly, cancer, diabetes, Pharma CEOs, China, John Lechleiter
AstraZeneca Won’t Seek Approval for Targacept Antidepressant
Bloomberg
Tuesday, March 20, 2012 - 10:18am
tags:
Targacept, antidepressants, AstraZeneca
Pfizer’s Rheumatoid Arthritis Pill: Not A Slam Dunk
Pharmalot
Tuesday, March 20, 2012 - 10:17am
tags:
Pfizer, rheumatoid arthritis, tofacitinib
Pozen's Final Results On Ulcer Safe Aspirin Can Send Shares Soaring
Seeking Alpha
Tuesday, March 20, 2012 - 10:15am
tags:
Pozen, asprin, ulcers, PA32540
Neurocrine Could Be A Major Biotech Comeback Story
Seeking Alpha
Tuesday, March 20, 2012 - 10:14am
tags:
Neurocrine, Abbott Laboratories, GSK
For Sale: Pfizer's Growth Prospects
Seeking Alpha
Tuesday, March 20, 2012 - 10:11am
tags:
Pfizer
An FDA Advisory Panel Doubleheader
Motley Fool
Tuesday, March 20, 2012 - 10:07am
tags:
FDA, advisory panels, Votrient, soft tissue sarcomas, GSK, Merck, ridaforolimus, Ariad Pharmaceuticals
FDA approves first low-cost versions of osteoporosis drug from 3 generic drugmakers
Yahoo/AP
Tuesday, March 20, 2012 - 10:04am
tags:
generics, FDA, osteoporosis, Boniva, Apotex, Orchid Healthcare, Mylan

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.